Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CHUGAI-PHARMACEUTICAL-CO--6491165/news/Chugai-Pharmaceutical-Presents-Results-of-Two-Pivotal-Phase-lll-Studies-for-its-Bispecific-Antibod-26625763/?utm_source=whatsapp&utm_medium=social&utm_campaign=share